Contineum Therapeutics (NasdaqGS:CTNM) Earnings Call Presentation
Corporate Presentation May 2026 Disclaimer This presentation by Contineum Therapeutics, Inc. ("Contineum", "We" or "Our) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1955. All statements other than statements of historical facts contained in this presentation, including without limitation statements regarding our future results of operations and financial position, future revenue, timing, progress and expected results of our clinical trials and ou ...